Atlas Trials

Biossil Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biossil Inc.

RecordFirmDate
Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype (NCT07282210)Biossil Inc.2026-08-13
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease (NCT02187003)Biossil Inc.2015-06-17

Track Biossil Inc. automatically

Every clearance here is in the API, with alerts when new ones post.